| Carlton Clinkscales, MD | |
|
601 E Hampden Ave, Suite 500, Englewood, CO 80113-3781 | |
| (303) 744-7078 | |
| (303) 744-0248 |
| Full Name | Carlton Clinkscales |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 35 Years |
| Location | 601 E Hampden Ave, Englewood, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699713081 | NPI | - | NPPES |
| 01346634 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0106X | Orthopaedic Surgery - Hand Surgery | 34663 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Littleton Adventist Hospital, Centura Health | Littleton, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopedic Centers Of Colorado | 2365714540 | 298 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Few animals are more problematic than the tiny African insect known to English speakers as the tsetse fly. This is the carrier of "sleeping sickness," an often deadly neurological illness in humans, as well as a disease that has killed millions of cattle, reshaping the landscape and economy in some parts of the continent.
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications to the United States Food and Drug Administration for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.
In this global development podcast, the Guardian's Annie Kelly is joined by Julia Bunting, head of the U.K. Department for International Development's reproductive health team; Yasmin Ahmed, senior regional director for Asia at Marie Stopes International; Neil Datta, coordinator of the European Parliamentary Forum on Population and Development; and Gita Sen, professor at the Centre for Public Policy at the Indian Institute of Management, for a discussion about family planning ahead of the July 11 London Summit on Family Planning.
› Verified 7 days ago
| Entity Name | Orthopedic Centers Of Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801339502 PECOS PAC ID: 2365714540 Enrollment ID: O20170823001317 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Few animals are more problematic than the tiny African insect known to English speakers as the tsetse fly. This is the carrier of "sleeping sickness," an often deadly neurological illness in humans, as well as a disease that has killed millions of cattle, reshaping the landscape and economy in some parts of the continent.
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications to the United States Food and Drug Administration for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.
In this global development podcast, the Guardian's Annie Kelly is joined by Julia Bunting, head of the U.K. Department for International Development's reproductive health team; Yasmin Ahmed, senior regional director for Asia at Marie Stopes International; Neil Datta, coordinator of the European Parliamentary Forum on Population and Development; and Gita Sen, professor at the Centre for Public Policy at the Indian Institute of Management, for a discussion about family planning ahead of the July 11 London Summit on Family Planning.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlton Clinkscales, MD 601 E Hampden Ave, Suite 500, Englewood, CO 80113-3781 Ph: (303) 744-7078 | Carlton Clinkscales, MD 601 E Hampden Ave, Suite 500, Englewood, CO 80113-3781 Ph: (303) 744-7078 |
News Archive
Bristol-Myers Squibb Company and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for an investigational fixed dose combination of ONGLYZA™ (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults.
Few animals are more problematic than the tiny African insect known to English speakers as the tsetse fly. This is the carrier of "sleeping sickness," an often deadly neurological illness in humans, as well as a disease that has killed millions of cattle, reshaping the landscape and economy in some parts of the continent.
Takeda Pharmaceutical Company Limited announced today that Takeda Global Research & Development Center, Inc., resubmitted two New Drug Applications to the United States Food and Drug Administration for alogliptin and the fixed-dose combination therapy alogliptin/pioglitazone, which combines alogliptin with pioglitazone in a single tablet.
In this global development podcast, the Guardian's Annie Kelly is joined by Julia Bunting, head of the U.K. Department for International Development's reproductive health team; Yasmin Ahmed, senior regional director for Asia at Marie Stopes International; Neil Datta, coordinator of the European Parliamentary Forum on Population and Development; and Gita Sen, professor at the Centre for Public Policy at the Indian Institute of Management, for a discussion about family planning ahead of the July 11 London Summit on Family Planning.
› Verified 7 days ago
Dr. Judith Emily Kopinski, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 Inverness Dr E Ste 300, Englewood, CO 80112 Phone: 303-695-6060 Fax: 303-369-7776 | |
John S Woodward Jr., M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 799 E Hampden Ave, Suite 400, Englewood, CO 80113 Phone: 303-789-2663 Fax: 303-788-4871 | |
Dr. Christopher Rolf Johnson, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 145 Inverness Dr E Ste 100, Englewood, CO 80112 Phone: 303-697-7463 | |
Philip Heyman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 E Hampden Ave, Suite 500, Englewood, CO 80113 Phone: 303-744-7078 Fax: 303-744-0248 | |
Trevor Jordan Wait, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 175 Inverness Dr W, Englewood, CO 80112 Phone: 720-848-0000 | |
Dr. Steven J Morgan, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 E Hampden Ave, Suite 515, Englewood, CO 80113 Phone: 303-209-2503 Fax: 303-761-0803 | |
James T Muffly, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 799 E Hampden Ave, Ste 310, Englewood, CO 80113 Phone: 303-788-7840 Fax: 303-788-7839 |